chrisvoncsefalvay/vaers-outcomes huggingface dataset:
upper front tooth (has a crown and post in it) feels traumatized now, extremely painful; headache; gums are itchy; throbbing up to my left nostril; Can't chew food; Face is tender; Gums are red; Gums are painful; This spontaneous case was reported by a consumer and describes the occurrence of GINGIVAL DISCOLOURATION (Gums are red), GINGIVAL PAIN (Gums are painful), DENTAL DISCOMFORT (upper front tooth (has a crown and post in it) feels traumatized now, extremely painful), MASTICATION DISORDER (Can't chew food) and FACIAL PAIN (Face is tender) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced GINGIVAL DISCOLOURATION (Gums are red), GINGIVAL PAIN (Gums are painful), MASTICATION DISORDER (Can't chew food) and FACIAL PAIN (Face is tender). On 15-Jan-2021, the patient experienced DENTAL DISCOMFORT (upper front tooth (has a crown and post in it) feels traumatized now, extremely painful), HEADACHE (headache) and GINGIVAL PRURITUS (gums are itchy). At the time of the report, GINGIVAL DISCOLOURATION (Gums are red), GINGIVAL PAIN (Gums are painful), DENTAL DISCOMFORT (upper front tooth (has a crown and post in it) feels traumatized now, extremely painful), MASTICATION DISORDER (Can't chew food) and FACIAL PAIN (Face is tender) had not resolved and HEADACHE (headache) and GINGIVAL PRURITUS (gums are itchy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.  Company Comment: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Info has been received from a consumer concerning a 13 month old female with no pertinent medical history or allergies who on 4/1/06 was vaccinated with MMRII. There was no concomitant medication. On 4/6/06, the pt developed a fever and cough. The pt's fever and cough persisted. The pt did not seek medical attention. Additional info is not expected.
Client came to the Health Dept 7/24/23 the error originated with the clients name being incorrect on the face sheet. Clients name was misspelled. No treatment needed. Parent made aware.
Pt developed Mildly erythematous, raised, umbilicated (some) papules on hands (palms fingers, wrists) and elbows.  Consulted CDC and felt to be "benign, Accrual papulovesicular eruption".
Pt presents to clinic with a rash, starting on the face and progressing down to trunk, very irritable. Mom reports fever 103 3 days prior. No treatment needed as of today.
Information has been received from healthcare worker referring to a 22 year old patient of unknown gender. Information about medical history and concurrent condition was not reported. The first dose of GARDASIL was administered on 08-OCT-2007; the second dose was on 19-SEP-2008 and the third dose was administered on 10-DEC-2008 (strength, dosage, frequency and route were all unspecified) (inappropriate schedule of vaccine administration). On 30-JUL-2015, the patient was vaccinated with the fourth dose of GARDASIL (lot # K010574 with expiration date of 30-JUL-2015; strength, dosage frequency and route unspecified) (extra dose administered). No adverse effects were reported. Additional information is not expected because the physician did not want to be contacted.
upper respiratory issues; feels cold; has no appetite; chills; tired and fatigue; This spontaneous case was reported by a consumer and describes the occurrence of RESPIRATORY DISORDER (upper respiratory issues), FEELING COLD (feels cold), DECREASED APPETITE (has no appetite), CHILLS (chills) and FATIGUE (tired and fatigue) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20 and 042L20a) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes. Concomitant products included LISINOPRIL, ACETYLSALICYLIC ACID (ASPRIN), ROSUVASTATIN and INSULIN for an unknown indication.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced RESPIRATORY DISORDER (upper respiratory issues), FEELING COLD (feels cold), DECREASED APPETITE (has no appetite), CHILLS (chills) and FATIGUE (tired and fatigue). At the time of the report, RESPIRATORY DISORDER (upper respiratory issues), FEELING COLD (feels cold), DECREASED APPETITE (has no appetite), CHILLS (chills) and FATIGUE (tired and fatigue) outcome was unknown.            Treatment information was not provided
Patient received Moderna COVID vaccine on 5/21/21 and 6/18/21. On 12/26/21, patient was tested positive for COVID. On 1/2/22, patient admitted to our inpatient facility with acute hypoxic respiratory failure due to COVID-19 pneumonia. As of today (1/5/22), patient is still admitted in the med/surg unit requiring high flow O2 and on dexamethasone.
8CM BY 10CM REDNESS AND SWELLING RIGHT THEIGH 2 HRS AFTER SHOT
VACCINE ERROR, ADMINISTERED AFTER AVAILABLE DATE TO BE USED. NOTIFICATION OF PFIZER BIVALENT TO END RECEIVED 9.1223 LATE AFTERNOON.
Upper respiratory infection, asthma exacerbation, bronchitis with non productive cough no fever @ day 9, seen in urgent care.  Azithromycin 500X3d, albuterol inhaler, QVar inhaler. Tesalon.  OTC expectorant Cough, malaise,fatigue still present today. Improving gradually.
A few hours after the vaccine I developed a fever, chills, a headache, muscle pain mainly in the hip and thigh area all which lasted about 20 hours.  The 2nd day I was a little dizzy with the headache lingering for about 2 days longer
Patient administered vaccine after the manufacture's date of expiration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine after the manufacture's date of expiration) in a 72-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 070H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 12-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 12-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine after the manufacture's date of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine after the manufacture's date of expiration) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported. The vial did not undergo any temperature excursions. Date the vial initially stored in the refrigerator was unknown. Treatment medications were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Non-significant live follow-up received. Reporter address updated.
Muscle aches, temp 100.2, fatigue, joint aches, headache, nausea- started around hour 8, slight improvement around hour 24, then worsened again, resolved mostly by hour 36, very residual symptoms after that, though arm itching started around hour 50
PT REQUESTED FLUZONE HD AS SHE WAS ABOUT TO TURN 65. TECHNICALLY A VACCINE ERROR AS SHE WAS 64 AT THE TIME OF VACCINATION. NO SIDE EFFECTS OR ISSUES ARE KNOWN.
Muscle ache Fatigue Chills Indigestion  Brain Fog Lightheadedness
Hospitalization PUI stated she has also experienced light sensitivity, wheezing, a burning sensation on the right side of her sinus cavity and a burning sensation in her chest. PUI stated that she is still feeling all symptoms except for the fever. PUI stated that due to sinus issues she has no sense of smell and her sense of taste is diminished. PUI is hospitalized at Medical Center since 7/5/21 and she stated she will be evaluated for discharge on 7/9/21. PUI stated she is receiving breathing treatments every 6 hours. PUI stated she has been told she does not have pneumonia, but that she does have Covid Lung (in both lungs).
Patient's left arm became red, swollen, and painful. Patient was given a steroid pack on 7/10 to relieve swelling and redness.  Patient still has pain radiating from left shoulder to left elbow as of 7/22/17.
Shingrix given 3/19/19 and 8/22/19. Shingles case on 2022; Shingles "light" case. Saw eye Dr.; Minimal scarring.; This case was reported by a consumer via sales rep and described the occurrence of vaccination failure in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 22nd August 2019, the patient received the 2nd dose of Shingrix. On 19th March 2019, the patient received the 1st dose of Shingrix. On 20th December 2021, 851 days after receiving Shingrix and 1007 days after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and scar. On an unknown date, the outcome of the vaccination failure and scar were unknown and the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the vaccination failure, shingles and scar to be related to Shingrix and Shingrix.     Additional Information: GSK Receipt Date: 24-Mar-2022 Reporter's Comments: The patient self-reported this report. The patient received both doses of Shingrix and had a light case of shingles just near her eye, which got resolved in 1 or 2 weeks. The patient also had minimal scarring. The patient wanted to make sure if it was ok, thus went to eye physician and had no complications. The patient asked not to be contacted. Additional Supportive Information: This case was considered as suspected vaccination failure since the details regarding laboratory test confirming shingles were unknown at the time of reporting.
One half hour after injections, pt was completely perspired. One hour later pt developed fever of 102 degrees ax. Fever reduced with alternating TYLENOL and ibuprofen a 3 hrs. Pt woke this am with prickly red rash all over body. Pt afebrile at visit. Mother advised to continue TYLENOL and ibuprofen. BENADRYL for rash prn.
Left shoulder pain. This is his nondominant shoulder. His pain began shortly after receiving his HPV vaccine on December 29, 2016. His pain is more periscapular and in the area of the upper trapezius. He notes the arm feels very weak now he has a hard time forward flexing or abducting the shoulder. He has been swimming competitively for senior high school and is unable to do so due to the pain and weakness. His pain does not radiate. He does not think his grip has been affected. He does have more pain sometimes at night. He woke this morning with pain he thinks he may have slept on his left side, which is not usual for him. He has no numbness or tingling. He's had no swelling. He has no history of similar symptoms. He has no history of trauma to the shoulder that he can recall. Patient diagnosed with Parsonage-Turner Syndrome (brachial neuritis) by Musculoskeletal Specialist.  He was referred onto Neurology.  Diagnosis confirmed by EMG.  Patient was admitted to the hospital and received two rounds of IVIG on 3/7/2015.  Patient continues to have slightly diminished muscle bulk of the left shoulder compared to the right. At most recent evaluation on 3/28/2016 he continues to have mild scapular winging when doing a wall pushup and has mild scapular dyskinesia with slow controlled shoulder abduction.  Full-strength with resisted internal and external rotation and supraspinatus testing, subcapsular slipped off test, shoulder flexion and abduction.  Full biceps and triceps strength.
No adverse effects; the patient was administered VAQTA via the subcutaneous route rather than the intramuscular route.; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, drug reactions, allergies, medical history, and concomitant therapies provided.   On 09-AUG-2019, the patient was vaccinated with hepatitis a vaccine, inactivated(VAQTA) (lot # S007769, expiration date was 24-JUL-2020) 1 dose via the subcutaneous route rather than the intramuscular route for prophylaxis(Incorrect route of product administration). No adverse effects reported.
Fever 102.2 (Ax) started day of vaccine 3/16/15. Slightly barky cough 2 days after vaccine 3/18/15. Tx- ibuprofen PRN fever, push fluids.
Influenza vaccine administered on 10/29/08.  Pt developed severe posterior left arm/shoulder pain the evening of 11/1/08, followed by left arm numbness and left hand tingling on 11/2/08.  Pt seen by N.P. on 11/3/08. Prescribed Flexeril and Ibuprofen.  F/U on 11/7 resulted in referral to a neurologist. Delay in this reporting is based on pt. being ruled out for presence of possible tumors in left arm. Neurologist diagnosed pt as having mild left brachial plexopathy. Tx: Prednisone 100mg tapering every 3 days by 20mg, Physical Therapy 2-3times per week/with Neuro Muscular Stimulation along with strength exercises for 6 weeks.
NOTICED RASH ABOUT 24 TO 36 HOURS AFTER THE INJECTION. IT HAD RESOLVED ITSELF AFTER 48 HOURS.
Facial and throat swelling without difficulty breathing, joint pain. Symptoms started roughly 2.5 days after administration.
Numbness to (L) arm from injection site to wrist. Symptoms resolved by appt with is on 11-10-11 at 9:30 am.
Patient was vaccinated in exam room and after 5 minutes patient was instructed to walk to the lab for additional testing.  The lab assistant  heard a knock on the wall and looked out into the hallway when she witnessed patient falling to floor.  She grabbed patient in time before he hit the floor.  The patient was quickly examined by physician who reports he had a tonic clonic seizure for 5-10 seconds.  The patient awoke after seizure and vital done (wnl) and juice was given.  The patient was brought back to room and assessed.  He was sent to ER for evaluation given neurologic sx after head injury.
Patient reports redness (approximately the size of a baseball) and swelling around injection site. Began about 2 weeks after dose and lasted around 8 days.  Reports that it did not bother her nor did it require treatment.
15 minutes after her dose, patient was leaving and fell to the floor.  She was unconscious briefly and woke up within a couple of seconds.  She was breathing heavy and 911 was called.  She stayed on the ground for about 10 minutes and refused treatment.  She kept asking not to start any IVs on her.  Patient eventually recovered and refused the ambulance.  Follow up call to her house later that day indicated she was doing fine and did not need any further treatments.
Experiencing side effects after booster; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Experiencing side effects after booster) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Experiencing side effects after booster). At the time of the report, VACCINATION COMPLICATION (Experiencing side effects after booster) outcome was unknown.            No concomitant medications reported. No treatment information was provided.
Within 5 minutes of injection, intense pain from feet to back of legs to back......could not move legs.   Ambulance attendants assessed.  BP 220/112.  After sitting, pain subsided. Refused transport due to Covid.  Came home.
Information has been received from a physician concerning a female who was vaccinated with a first dose of HPV vaccine (yeast). Subsequently the patient complained of pain and then fainted within minutes of administration. Subsequently, the patient recovered without any additional treatment.  Additional information has been requested.
nausea; strong headache; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea) and HEADACHE (strong headache) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced NAUSEA (nausea) and HEADACHE (strong headache). At the time of the report, NAUSEA (nausea) and HEADACHE (strong headache) outcome was unknown. Not Provided
Left upper arm with one 1.5 cm round area of erythema, warm, raised. Another 2.5 cm round area of erythema, warm, raised slightly, tender but no drainage.
Covid Positive; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid Positive) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced COVID-19 (Covid Positive). The patient was treated with MONOCLONAL ANTIBODY 17-1A for COVID-19, at an unspecified dose and frequency. At the time of the report, COVID-19 (Covid Positive) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information was reported.   This case was linked to MOD-2021-066629 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 31-Mar-2021: Dosing date, batch number and con. med. info. corrected.
Patient received initial dose of Covid-19 vaccine. During observation period, patient reported progressive pruritus in left arm. While evaluating patient, pruritus progressed to right arm. At that time, patient reported significant reaction previously to influenza vaccine with similar initial presentation. At no point did patient report SOB, increased heart rate, or chest tightness. While waiting for transport to ER, patient reported progressive burning while continuing to have pruritus
Patient had itching and hives. Symptoms started within 10 minutes of administration. Patient was given oral diphenhydramine, which she states decreased the intensity of the itching.
Entire body feels completely weakened and pained,like I was hit by a car. Nausea. Language is slurred and I am mixing up words. I feel extremely fatigued. Even my face is sensitive to pain and touch, it hurt to rub lotion on my face.
The patient was given the Adjuvant Suspension component of the vaccine without reconstituting with the Lyophilized Antigen before the injection. This was caught with looking at inventory 4 days later and we informed the patient. He reported localized left arm pain but no other problems.
2 days post vax pt awakened with legs hurting, upset stomach, cranky and fingers hurt. By that afternoon pt developed a fever of 101, chills, jerking severely when sleeping, dozing on and off all day. The next two days pt experienced diarrhea, upset stomach, crying, cancor sores. The pt then developed red right eye, cranky, and crying, legs sore. This continued for months. Pt is no trying to reverse immune function with homeopathy.
blister the day after vaccination and it went away, but burning  inside of the mouth and throat replaced the blister. Patient saw primary care and told to rinse mouth with warm salt water but symptoms still persist. Patient still experience difficulty swallowing and drink due to burning sensation
Patient felt weak, dizzy, and faint. EMS was contacted. EMS transported patient in stable condition to the ED for further evaluation and treatment. No airway or other life threats were identified.
Patient developed diffuse urticarical rash on arms. Was given a start dose of flu vaccine prior to developing rash. Was given a prednisone taper to minimize rash.
This is a prospective pregnancy case. This 31-year-old female subject enrolled in an open label study. The subject received Flu Seasonal QIV Dresden 0.5 ml on 1st November 2016. The subject's estimated date of delivery was 20th May 2017. The subject received Flu Seasonal QIV Dresden during the first trimester of pregnancy. On an unknown date, an unknown time after receiving Flu Seasonal QIV Dresden, the subject developed vaccine exposure during pregnancy (Non-serious). The outcome of vaccine exposure during pregnancy was unknown. The pregnancy was ongoing. Additional details were provided as follows: The patient received a dose of FLUARIX QUADRIVALENT (batch number B5592, expiry date 20th June 2017). The date of last menstrual period was unknown. Follow up information was received from nurse on 18th January 2017: The patient's demographic details were updated. The date of last menstrual period was updated as 13th August 2016 and number of fetus was updated as 1. The patient had a normal conception. The patient received the vaccine at 11 weeks and 3 days of gestation. The VAERS details were updated. Follow up information was received from nurse on 27th June 2017: This case was upgraded to serious for event stillbirth (serious criteria GSK medically significant). On 8th May 2017, 188 days after vaccination with FLUARIX QUADRIVALENT, the foetus died inside the utero (near term). The cause of death was not specifically known but could have been a cord wrapped around the baby. The nurse does not wish to reach out to the mother and drag out a traumatic experience and be delicate. The nurse wants safety to reach out to the physician who would be better able to answer questions.
Fever up to 101.4, severe body aches, pounding headache, severe fatigue, moderate tinnitus in both ears L>R, mild injection site soreness,  mild dizziness, mild nausea. Symptoms began 8-10  hours after injection, worse symptoms ~22 hours later. Diminished fever, body aches and HA after ~42. Continued tinnitus and mild fatigue. Tylenol taken with some relief in fever, body aches and headache.
PATIENT DESCRIBED "TINGLING/NUMBNESS" ALL THROUGHOUT LEFT ARM, WHICH IS THE INJECTION SITE OF IMMUNIZATION. DID NOT RESOLVE WITH REGULAR USE OF IBUPROFEN.
Pt was a healthy 2mo old; the 1st sz occurred approx 12 hrs p/1st DTP shot; w/time, sz disorder became progressively worse & pt became developmentally delayed; seizures occur daily w/frequent episodes of status epilepticus requiring ER tx;